House panel questions resignation of top FDA official

Your Health Matters

A view shows the U.S. Food and Drug Administration (FDA) logo at its headquarters in Silver SpringBy Toni Clarke (Reuters) – A House of Representatives panel is investigating the circumstances surrounding the resignation from the Food and Drug Administration of its acting deputy commissioner for medical products and tobacco. In a letter to FDA Commissioner Margaret Hamburg on Monday, Republicans on the Energy and Commerce Committee demanded more information about the role played at the agency by Dr Leona Brenner-Gati, a former Johnson & Johnson executive, who resigned from the FDA on May 3. …

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave